Infectious Disease Antibodies

Monoclonal and polyclonal antibodies against infectious diseases are available at ABI. Infectious disease antibodies from ABI are highly specific in immunoassays.

ABI offers monoclonal and polyclonal antibodies against specific human viral proteins. ABI hybridomas are produced by standard fusion and selection methodologies to yield the highest quality monoclonal antibodies possible for a specific application.

ABI’s antibodies are purified by immunoaffinity chromatography using Protein G Agarose or Protein A Sepharose. Polyclonal antibodies are supplied as undiluted hyperimmune serum or purified IgG.

ABI’s antibodies are evaluated according to the following methods

  • Protein concentration by Bradford assay with BGG as the standard
  • Isotyping of IgG for monoclonal antibodies
  • Specificity by Western blot
  • Sensitivity/specificity by ELISA and/or IFA
  • Immunohistochemistry
  • Purity by SDS-PAGE

Monoclonal Antibodies

  • Host: mouse or rat
  • Specific and sensitive
  • Produced from ascities fluid or cell culture supernatant

Polyclonal Antibodies

  • Host: rabbit
  • Broadly and strongly reactive
  • Produced using highly purified antigens or synthetic peptides
  • Produced from hyperimmune rabbit serum and supplied as undiluted hyperimmune serum

Antibody FAQs

Catalog #sort icon Namesort icon Size Storage Bio Cat.
13-102-100 HIV-1 anti-p24 gag 100 µg -20°C
13-103-100 HIV-1 anti-p17 gag 100 µg -20°C
13-104-100 HIV-1 anti-gp41 env 100 µg -70°C
13-105-100 HIV-1 anti-gp120 env (aa 307-320) 100 µg -20°C
13-108-100 HIV-1 anti-gp120 env 100 µg -20°C
13-112-100 SIVmac251 anti-p27 gag (does not react w/HIV-1 or -2 proteins) 100 µg -20°C
13-113-100 SIVmac251 anti-p27 gag (cross reacts w/HIV-1 or -2 proteins) 100 µg -20°C
13-137-100 HIV-1 anti-p66/51 pol 100 µg -20°C
13-138-100 HHV-6A Early Protein p41/38 100 µg -20°C
13-139-001 HHV-6A Early Protein, p41/38 (cell culture supernatant) 1 ml -20°C
13-150-100 EBV anti-(EA-R) protein p17 100 µg -20°C
13-152-100 HIV-1 anti-nef (aa 35–50) 100 µg -20°C
13-155-100 HIV-1 anti-nef (aa 150–158) 100 µg -20°C
13-156-100 EBV Nuclear Antigen-1 (EBNA-1) MAb 100 µg -20°C
13-157-100 HIV-1 anti-nef (aa 163–173) 100 µg -20°C
13-160-100 HIV-1 anti-nef (aa 195-205) 100 µg -20°C
13-203-000 HIV-1IIIB rabbit anti-p24 Polyclonal .50 ml -20°C
13-204-000 HIV-1IIIB rabbit anti-gp120 Polyclonal .50 ml -20°C
13-210-100 KSHV/HHV-8 MAb to ORF73 100 µg -20°C
13-211-100 KSHV/HHV-8 MAb to ORF59 100 µg -20°C
13-212-100 KSHV/HHV-8 MAb to ORF K8.1 A/B 100 µg -20°C
13-213-100 KSHV/HHV-8 MAb to ORF K8.1 A 100 µg -20°C
13-214-050 KSHV/HHV-8 Rabbit antibody vIL-6 Polyclonal 50 µg -20°C
13-216-100 HHV-6A/B MAb to early Phosphoprotein p41 100 µg -20°C
13-217-001 HHV-6A MAb to gp82/105 (cell culture supernatant) 1 ml -20°C
13-218-100 HHV-6A/B MAb to gp116/64/54 100 µg -20°C
13-219-001 HHV-6A/B MAb to gp116/64/54 (cell culture supernatant) 1 ml -20°C
13-222-100 Rabbit anti-Vaccinia polyclonal antibody    100 µg -20°C
13-223-001 HHV-7 MAb (clone KR4) (Ultrafiltered cell culture supernatant) 1 ml -20°C